KCNJ2 and Myocardial fibrosis: Reducing myocardial fibrosis, upregulating ion channels including Kv1.4, Kv1.5, KvLQT1, Kir2.1, and Nav1.5, and enhancing PI3K, AKT, and eNOS mRNA and protein expression.